$7.47
-0.09-1.19%
At close: -
$7.47
0.000.00%
After Hours: 4:02 PM EDT
Comments
Loading...
INmune Bio (INMB) Forecast
NewsEarningsINmune Bio (INMB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
INmune Bio Stock Price, Quotes and Forecasts | NASDAQ:INMB | Benzinga
Explore INmune Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INMB.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy INmune Bio (INMB) stock?
You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.
Who are INmune Bio (INMB) competitors?
Other companies in INmune Bio’s space includes: Innate Pharma (NASDAQ:IPHA), Voyager Therapeutics (NASDAQ:VYGR), Tango Therapeutics (NASDAQ:TNGX), Tevogen Bio Holdings (NASDAQ:TVGN) and Sangamo Therapeutics (NASDAQ:SGMO).
What is the forecast, or price target, for INmune Bio (INMB) stock?
INmune Bio has a consensus price target of $18.29.
What is the current price for INmune Bio (INMB)?
The stock price for INmune Bio (NASDAQ: INMB) is $7.47 last updated April 15, 2025 at 4:02 PM EDT.
Does INmune Bio (INMB) pay a dividend?
There are no upcoming dividends for INmune Bio.
When is INmune Bio (NASDAQ:INMB) reporting earnings?
INmune Bio’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is INmune Bio (INMB) going to split?
There is no upcoming split for INmune Bio.
What sector and industry does INmune Bio (INMB) operate in?
INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.